CompaniesAplagon
Aplagon logo

Aplagon

active
Helsinki, Finland
Founded 2009
Website
About

Antithrombotics

Areas of Focus

Categories

Biologics & BiopharmaceuticalFinland
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

10

By Phase

EARLY_PHASE1: 1

By Status

RECRUITING: 1

Recent Trials

NCT06204237Lead Sponsor
Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)
EARLY_PHASE1Recruiting
10 participants
Started: Feb 1, 2024 · Completed: Jun 30, 2025
Locations (1)
Headquarters
Helsinki, Finland
Map

Loading map...